SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886163-20-000118
Filing Date
2020-11-04
Accepted
2020-11-04 16:19:16
Documents
1
Period of Report
2020-11-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 2873
  Complete submission text file 0000886163-20-000118.txt   4256
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 11085 NORTH TORREY PINES RD., SUITE 300 LA JOLLA CA 92037
Business Address
Patel Sunil (Reporting) CIK: 0001503062 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 201286953